Registration Dossier

Toxicological information

Skin sensitisation

Currently viewing:

Administrative data

Endpoint:
skin sensitisation: in vivo (non-LLNA)
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: small number of animals tested; reactions should have been scored additionally at 48 hours

Data source

Reference
Reference Type:
publication
Title:
The sensitization potential of some perfume ingredients tested using a modified Draize procedure.
Author:
Sharp DW
Year:
1978
Bibliographic source:
Toxicology 9: 261-271

Materials and methods

Test guideline
Qualifier:
equivalent or similar to
Guideline:
OECD Guideline 406 (Skin Sensitisation)
Deviations:
yes
Remarks:
The equivalent total dose was administered on one occasion as 4 intradermal injections, each 2.5 times the Injection Challenge Concentration (ICC)
Principles of method if other than guideline:
Method: other: see freetext ME
GLP compliance:
not specified
Type of study:
Draize test

Test material

Reference
Name:
Unnamed
Type:
Constituent
Details on test material:
Test substance: p-cresol, not specified further

In vivo test system

Test animals

Species:
guinea pig
Strain:
Hartley
Sex:
male/female
Details on test animals and environmental conditions:
TEST ANIMALS
- Weight at study initiation: 350 g
- Housing: 2/per cage, same sex
- Diet ad libitum
- Water ad libitum
- Acclimation period:


Study design: in vivo (non-LLNA)

Inductionopen allclose all
Route:
intradermal
Vehicle:
no data
Concentration / amount:
induction concentration: 0.1%
Challenge concentration 10 %
Challengeopen allclose all
Route:
intradermal and epicutaneous
Vehicle:
no data
Concentration / amount:
induction concentration: 0.1%
Challenge concentration 10 %
No. of animals per dose:
10
Details on study design:
10 guinea pigs (4 males and 6 females or vice versa). Both flanks of each  guinea 
pig were shaved, intradermal injections or topical applications  were performed 
without occlusion. Primary irritation tests were performed to determine the suitable  concentrations.

METHOD: Each animal was injected intradermally with 0.1 ml of TS at 2.5 times the 
determined injection challenge concentration (ICC) of 0.1 %  at 4 sites  
which overlie the 2 auxilliary and the 2 inguinal lymph nodes. 14 days  later 
each animal was challenged intradermally in one flank and topically  in the
 other with 0.1 ml aliquots of TS at the respective ICC and  application 
challenge concentration (ACC; 10%). 24 hours later the  reactions were scored. 

To confirm the result, the procedure was repeated  including a confirmatory 
challenge with controls.

1st application: Induction 0.1 % intracutaneous
2nd application: Challenge 10 % intracutaneous
3rd application: Challenge 10 % other: topical application
Challenge controls:
At each challenge with controls 4 previously untreated animals of the same sex and similar weight to the test animals were treated intradermally and
topically on opposite flanks with 0.1 ml aliquots of test substance at the ICC and ACC respectively
Positive control substance(s):
not specified

Results and discussion

Positive control results:
no data

In vivo (non-LLNA)

Results
Reading:
1st reading
Hours after challenge:
24
Group:
other: no details given
Dose level:
10 %
No. with + reactions:
0
Total no. in group:
10
Clinical observations:
no data
Remarks on result:
other: Reading: 1st reading. . Hours after challenge: 24.0. Group:

Applicant's summary and conclusion

Interpretation of results:
not sensitising
Remarks:
Migrated information
Executive summary:

p-cresol did not reveal sensitizing potency in a modified Draize test with guinea pigs.